Lifecore Biomedical, Inc.
Health
Performance
5.3
Risk
Sell
Buy
Curious about the Scores? Learn more.

Lifecore Biomedical, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

23.01.2026
Short-term strength kicking in. Early signs of life.
22.01.2026
Respawned at 1 HP. Still fragile, but back in play.
16.01.2026
Signs of control returning. Still shaky, but not chaos.

Lifecore Biomedical, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Lifecore Biomedical, Inc. do? Business model and key facts

Get the full picture of Lifecore Biomedical, Inc.: what it builds, where it operates, and how it makes money.

Lifecore Biomedical, Inc. Profile

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees (FY): 524

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was incorporated in 1986 and is headquartered in Santa Maria, California.

shop
Company facts
Paul Josephs
CEO
524
Employees worldwide
shop
Performance
45.71%
Last 12 months
-19.5%
Last 5 years
shop
Growth
$128,87M
Revenue year
$-38.717.000
Net income
shop
Valuation
$324,83M
Market Cap
-6.04
Price/Earnings Ratio

Stocks related to Lifecore Biomedical, Inc.

Selected based on industry alignment and relative market positioning.

SNDL
SNDL Inc.
1.60
+0.63%
8.7
Sell
Buy
SNDL Inc.
SIGA
SIGA Technologies, Inc.
6.82
+0.44%
8.3
Sell
Buy
SIGA Technologies, Inc.
ORGO
Organogenesis Holdings Inc.
3.99
+1.01%
9.4
Sell
Buy
Organogenesis Holdings Inc.
EOLS
Evolus, Inc.
4.95
+2.70%
8.5
Sell
Buy
Evolus, Inc.
OGI.TO
OrganiGram Holdings Inc.
2.23
+1.83%
7.8
Sell
Buy
OrganiGram Holdings Inc.

Lifecore Biomedical, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.